Developer of small molecule therapeutics for cancer. The company has discovered an anticancer protein neutrophil elastase ELANE released from neutrophils. It activates a pathway of the innate immune system with anti-cancer activity.
← All startups
Onchilles Pharma
Series ADeveloper of small molecule therapeutics for cancer. The company has discovered an anticancer protein neutrophil elastase ELANE released from neutrophils.
About
Institutional investors
LYZZ Capital
Latest coverage
📰 Browse funding news — rounds, valuations, and market moves for founders.
Investor directory
🗂️ See who's investing in Life Sciences — full fund directory with check size and geography.